A calculation device is provided with: an acquisition unit that acquires an acetone concentration in a gas constituent discharged from a user and measured; an estimation unit that estimates a calorie balance corresponding to the acetone concentration acquired by the acquisition unit based on a predetermined correlative relationship between acetone concentrations and calorie balance; and a processing execution unit that executes predetermined processing using an estimation result of the estimation unit.

A device for providing a calibration fluid, in particular a nitrogen oxide, for calibrating a respiratory gas analysis device, includes a first interface for connecting a chamber of the device to a measurement path of the respiratory gas analysis device, a first opening for introducing a reactant carrier with a first reactant into the chamber, and a contact element. The contact element is arranged in the chamber relative to the first opening such that when the reactant carrier is introduced, a contact of the contact element with the reactant carrier is facilitated in order to trigger a chemical reaction of the first reactant so as to generate the calibration fluid. The disclosure further relates to a system, a reactant carrier, and a method for providing a calibration fluid for calibrating a respiratory gas analysis device.

In examples, there is a method comprising receiving an esophageal gas sample at a nitric oxide sensor, the nitric oxide sensor generating a signal indicative of the amount of nitric oxide in the esophageal gas sample, the nitric oxide sensor outputting the signal, and, based on the signal, determining the amount of nitric oxide in the esophageal gas sample.

A bioaerosol detector is operated in accordance with one or more first inputs. Operating the bioaerosol detector includes filtering pathogens from the air, extracting genetic material from the filtered pathogens, and analyzing the extracted genetic material to identify the filtered pathogens. While operating the bioaerosol detector in accordance with the one or more first inputs, a change is identified in an operating condition for the bioaerosol detector. In response, the bioaerosol detector is operated in accordance with one or more second inputs. At least one input of the one or more second inputs is distinct from a respective input of the one or more first inputs.

An excreta determination device includes a data acquisition unit that acquires first time series data indicating hydrogen concentration in a space inside a toilet bowl measured by an internal sensor arranged inside the toilet bowl, an excreta determination unit that determines whether or not one who excreted has farted based on the first time series data of the hydrogen concentration, and a determination result output unit that outputs a determination result, and the excreta determination unit determines that the one who excreted has farted when the value of the hydrogen concentration in the first time series data exceeds a threshold value.

A bioaerosol detector is operated in accordance with one or more first inputs. Operating the bioaerosol detector includes filtering pathogens from the air, extracting genetic material from the filtered pathogens, and analyzing the extracted genetic material to identify the filtered pathogens. While operating the bioaerosol detector in accordance with the one or more first inputs, a change is identified in an operating condition for the bioaerosol detector. In response, the bioaerosol detector is operated in accordance with one or more second inputs. At least one input of the one or more second inputs is distinct from a respective input of the one or more first inputs.

A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user, and the application reports measurement data to a remote system.

Systems and methods are provided for detecting potentially fatal, and non-fatal diseases in an non-invasive, low-cost, and reliable manner by detecting the trace presence of volatile organic compounds (VOCs) in the human breath. The systems and methods can be home-based, non-invasive systems and methods for diagnosing CLD (chronic liver disease), CKD (chronic kidney disease), and other diseases using lifestyle-based, repetitive detection of VOCs in the human breath and an adaptive machine learning algorithm.

Methods and systems are disclosed for the detecting of whether a subject has a lung disorder such as asthma, tuberculosis or lung cancer. Monitoring the subject's health and prognosis is also disclosed.

Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.